Bioimpedance Analyzers Market Size, Share, Trends, & Industry Analysis Report
By Product (Multiple-frequency, Single-frequency, and Dual-frequency), By Modality, By Application, By End Use, and By Region -Market Forecast, 2025 – 2034
- Published Date:Sep-2025
- Pages: 110
- Format: PDF
- Report ID: PM2172
- Base Year: 2024
- Historical Data: 2020 - 2023
Overview
The global bioimpedance analyzer market size was valued at USD 570.80 million in 2024. The market is projected to grow at a CAGR of 10.00% during 2025 to 2034. Key factors driving demand for bioimpedance analyzers include the rising prevalence of chronic diseases, increasing global health awareness, and growing focus on preventative care
Key Insights
- The multiple-frequency bioimpedance devices segment accounted for the largest revenue in 2024 due to their ability to calculate impedances at diverse frequencies.
- The fitness club and wellness centers segment held the largest revenue share in 2024, owing to the rising awareness regarding health and fitness around.
- North America accounted for the largest share in the global market in 2024, owing to growing government initiatives for promoting a healthy lifestyle.
- Asia Pacific is expected to grow at the fastest CAGR across the globe in the approaching years, due to factors such as rising R&D activities.
Industry Dynamics
- The growing incidence of lifestyle diseases such as obesity is propelling the market growth by creating a need for precise measurement of the muscle, bone, and fat in the human body.
- The increase in healthcare spending among the general population is leading to high demand for bioimpedance analyzers.
- Technological innovations in bioimpedance analyzers are creating a lucrative market opportunity.
- Inconsistency in the accuracy of different bioimpedance analyzers is projected to hamper the market growth.
Market Statistics
- 2024 Market Size: USD 570.80 Million
- 2034 Projected Market Size: USD 1,479.14 Million
- CAGR (2025-2034): 10.00%
- North America: Largest Market Share
To Understand More About this Research: Request a Free Sample Report
AI Impact on Bioimpedance Analyzers Market
- AI refines bioimpedance measurements and reduces errors.
- AI helps in forecasting risks like obesity by analyzing body composition data.
- AI supports individualized fitness and nutrition plans.
- AI helps in real-time tracking and integration with telehealth platforms.
The bioimpedance analyzers demand is driven owing to the factors such as the rising number of government and organizational initiatives for promoting physical activity and healthcare coupled with growing responsiveness regarding the healthy lifestyle. Also, the increasing volume of obese patients, as well as the rising prevalence of metabolic disorders, is attributed to the market growth. Furthermore, growing spending on healthcare services, technological innovations in bioimpedance analyzers, and increasing fitness clubs along with sports rehabilitation centers are creating lucrative growth opportunities for market development around the world.
The outbreak of COVID-19 may exhibited a positive impact on the bioimpedance analyzers market. As per the World Health Organization (WHO), in Europe, about 95% of mortalities were caused in 60 and more year’s patients, and over 50% of worldwide deaths include people aged 80 years and older. Likewise, WHO reported that around every 8 in 10 deaths suffers from at least one health issue such as diabetes, CVD, and hypertension. Thus, it may created a positive influence on the bioimpedance analyzers industry.
The coronavirus lessens appetite and leads to the breakdown of muscle mass, which causes the occurrence of muscle mass loss and malnutrition. So, it is one of the significant factors for obese people, as they contain very low muscle mass. For instance, in Europe, practical guidance for the nutritional management of COVID-19 patients is provided by the European Society for Clinical Nutrition and Metabolism (ESPEN), which majorly emphasizes the significance of muscle mass. Hence, these factors propel the bioimpedance analyzers industry demand as assessment of body composition and muscle mass during hospitalization and also afterward are an extremely important factor for safeguarding the patient’s life.
Know more about this report: request for sample pages
Industry Dynamics
Growth Drivers
The growing incidence of lifestyle diseases acts as a major driving factor for market. In the modern era, changing the standard of living may lead to unhealthy lifestyles such as rising consumption of junk foods, sedentary work environments, as well as growing mobility automation. Thus, these factors are leading to the prevalence of various lifestyle diseases like diabetes, obesity, high blood pressure, etc. For instance, as per the Centers for Disease Control (CDC), the occurrence of obesity increased to 42.4 in 2019 from 30.5 in 2000. Now, obesity is considered an epidemic across the globe. Nearly 57.8% of adults are likely to be categorized as the obsessed population, according to the World Health Organization (WHO). Moreover, obesity is termed as an epidemic majorly in the low and middle income as well as developed nations. Hence, these factors may fuel the adoption of the bioimpedance analyzers due to the rising need for precise measurement of the muscle, bone, and fat in the human body, which, in turn, propel bioimpedance analyzers market growth.
Report Segmentation
The market is primarily segmented on the basis of product, modality, application, end use, and region
|
By Product |
By Modality |
By Application |
By End Use |
By Region |
|
|
|
|
|
Know more about this report: request for sample pages
Insight by Product Type
Based on the product type, the multiple-frequency bioimpedance devices segment accounted for the largest revenue in the global bioimpedance analyzers market in 2024, due to their ability to calculate impedances at diverse frequencies. The growing popularity and awareness for the availability of multiple-frequency bioimpedance devices, along with the features of the devices such as it precisely computes the body composition, also supportted the segment demand. Furthermore, these devices are lightweight and small in size, which can be easily operated by the house settings for monitoring the health of the entire family, further contributed to the segment growth across the globe.
The single-frequency bioimpedance devices are expected to show the fastest CAGR growth in the near future. This is attributed to growing need for measuring total body water and fat-free mass, as well as estimation of the extracellular and intracellular body water.
Insight by End Use
Among the end use segment, the fitness club and wellness centers segment accounted for the largest revenue share in 2024 and is expected to lead the market in the forecasting years. The rising awareness regarding health and fitness around the world is the key driving factor for the segment demand. For some past decades, the presence of wellness centers and fitness clubs has increased significantly, resulting in the rising focus on health and fitness among the population, which, in turn, boosts the segment growth.
The home user segment is projected to be the fastest-growing segment across the market in the coming years. The constant technological developments and growing adoption of bioimpedance analyzers are positively influencing the segment demand. The use of the bioimpedance analyzer is growing owing to assessing the body composition for maintaining health and wellness. This tool can easily operate without the help of a professional. Thus, it may act as a catalyzing factor for the segment demand in the near future.
Geographic Overview
Geographically, North America led the revenue shares in the global market in 2024 and is likely to dominate the market over the upcoming period. The growing government initiatives for promoting a healthy lifestyle is escalating the number of fitness clubs and centers, which is accelerating the market demand. The increasing obesity rate among the population in the region also contributed the regional dominance. For instance, in 2018, in the United States, obesity costs approximately USD 149 billion in annual medical expenditures as per the data published by the State of Obesity. The study observed that nearly half of these expenses were compensated by the financed Medicaid and Medicare programs.
Moreover, Asia Pacific is expected to grow at the fastest CAGR across the globe in the approaching years, due to the factors such as rising R&D activities along with emerging economies like China and India. Moreover, increasing inclination towards the health and fitness activities and growing obese population is creating significant opportunities to the venture capitalists and investors in the near future. Thus, the lesser number of physical activities and growing consumption of fast food are the factors that are creating lucrative opportunities in the approaching years in the region.
Competitive Insight
Compnaies in the market are activiely developing advanced analyzers to attract tech-savvy consumers. Major players in the market are working to capture market share by expanding their profitability share. These companies are also involved in strategic planning and expansion to caputure the industry share. This is leading to high competion among the existing players. Some of the major players operating the global market include Bio-Medical Electronics Co., Ltd., Bioparhom, BioTekna, Charder Electronic Co., Ltd, EVOLT 360, Fook Tin Technologies Ltd., InBody, Maltron International, Medical Electronics Co, Omron Corporation, RJL Systems, seca GmbH & Co. KG, SELVAS Healthcare, Tanita Corporation, Xiaomi, Guangzhou Beautylife Electronic Technology Co., Ltd.
Bioimpedance Analyzers Market Report Scope
|
Report Attributes |
Details |
|
Market size value in 2024 |
USD 570.80 million |
|
Revenue forecast in 2025 |
USD 626.79 million |
| Revenue forecast in 2034 | USD 1,479.14 million |
|
CAGR |
10.00% from 2022 - 2030 |
|
Base year |
2024 |
|
Historical data |
2020 - 2023 |
|
Forecast period |
2025 - 2034 |
|
Quantitative units |
Revenue in USD Million and CAGR from 2025 to 2034 |
|
Segments covered |
|
|
Regional scope |
|
|
Key Companies |
Bio-Medical Electronics Co., Ltd., Bioparhom, BioTekna, Charder Electronic Co., Ltd, EVOLT 360, Fook Tin Technologies Ltd., InBody, Maltron International, Medical Electronics Co, Omron Corporation, RJL Systems, seca GmbH & Co. KG, SELVAS Healthcare, Tanita Corporation, Xiaomi, Guangzhou Beautylife Electronic Technology Co., Ltd. |
FAQ's
• The global market size was valued at USD 570.80 million in 2024 and is projected to grow to USD 1,479.14 million by 2034.
• The global market is projected to register a CAGR of 10.00% during the forecast period.
• North America dominated the market in 2024
• A few of the key players in the market are Bio-Medical Electronics Co., Ltd., Bioparhom, BioTekna, Charder Electronic Co., Ltd, EVOLT 360, Fook Tin Technologies Ltd., InBody, Maltron International, Medical Electronics Co, Omron Corporation, RJL Systems, seca GmbH & Co. KG, SELVAS Healthcare, Tanita Corporation, Xiaomi, Guangzhou Beautylife Electronic Technology Co., Ltd
• The multiple-frequency analyzers segment dominated the market revenue share in 2024.
© 2025 Polaris Market Research and Consulting. All rights reserved
